Probable early-onset alzheimer's disease in an apolipoprotein E2 homozygote
Objective: To describe a case of early-onset Alzheimer's disease (AD) in an apolipoprotein (Apo) ε2/ε2 homozygote. Background: Apo ε2/ε2 is the rarest of the ApoE genotypes, representing only 1.4% of the population. Cognitive decline in ApoE ε2 homozygotes has rarely been reported. Case Report/Methods: We report a 58-year-old Apo ε2/ε2 female who meets clinical criteria for probable AD as confirmed by neuropsychological testing, positron emission/computed tomography scan, CSF analysis and genetic screening for known mutations. Results: The clinical course is typical of AD, with progressive cognitive and functional decline. Conclusion: Clinically confirmed early-onset AD is atypical in ApoE2 homozygotes but can occur. © 2010 S. Karger AG, Basel.
Dementia and Geriatric Cognitive Disorders
Digital Object Identifier (DOI)
Cole, Lauren; Belden, Christine; Jacobson, Sandra; Liebsack, Carolyn; Myers, Kent; Reninger, Cornelia; Berk, Camryn; and Sabbagh, Marwan N., "Probable early-onset alzheimer's disease in an apolipoprotein E2 homozygote" (2010). Neurology. 1004.